These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7008658)

  • 1. Double-blind placebo-controlled studies with flunarizine in venous insufficiency.
    Roeckaerts F; Vanden Bussche G
    Angiology; 1980 Dec; 31(12):833-45. PubMed ID: 7008658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mendenopoulos G; Manafi T; Logothetis I; Bostantjopoulou S
    Cephalalgia; 1985 Mar; 5(1):31-7. PubMed ID: 3886152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine.
    Louis P
    Headache; 1981 Nov; 21(6):235-9. PubMed ID: 7031016
    [No Abstract]   [Full Text] [Related]  

  • 5. Flunarizine, a new preventive approach to migraine. A double-blind comparison with placebo.
    Frenken CW; Nuijten ST
    Clin Neurol Neurosurg; 1984; 86(1):17-20. PubMed ID: 6325065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy.
    Overweg J; Binnie CD; Meijer JW; Meinardi H; Nuijten ST; Schmaltz S; Wauquier A
    Epilepsia; 1984 Apr; 25(2):217-22. PubMed ID: 6705752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine.
    Sørensen PS; Hansen K; Olesen J
    Cephalalgia; 1986 Mar; 6(1):7-14. PubMed ID: 3516409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunarizine, a calcium entry blocker in migraine prophylaxis.
    Amery WK; Caers LI; Aerts TJ
    Headache; 1985 Jul; 25(5):249-54. PubMed ID: 3897128
    [No Abstract]   [Full Text] [Related]  

  • 9. [Flunarizine in the therapy of chronic cerebrovascular insufficiency. Multicentric controlled study].
    Arrigo A; Lottici P; Alfonsi E; Terraneo GB
    Clin Ter; 1984 Sep; 110(6):541-8. PubMed ID: 6238768
    [No Abstract]   [Full Text] [Related]  

  • 10. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine.
    Amery WK
    Headache; 1983 Mar; 23(2):70-4. PubMed ID: 6343298
    [No Abstract]   [Full Text] [Related]  

  • 11. Brain hypoxia in migraine: pathophysiologic and therapeutic implications.
    Amery WK
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S62-5. PubMed ID: 7045147
    [No Abstract]   [Full Text] [Related]  

  • 12. Flunarizine in vertigo. A double-blind placebo-controlled cross-over evaluation of a constant-dose schedule.
    Oosterveld WJ
    ORL J Otorhinolaryngol Relat Spec; 1982; 44(2):72-80. PubMed ID: 7041040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of flunarizine in chronic headache. Double-blind study of placebo and amitriptyline].
    Canepari C; Riva M; Erminio F
    Clin Ter; 1985 Dec; 115(6):463-8. PubMed ID: 3913563
    [No Abstract]   [Full Text] [Related]  

  • 14. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mentenopoulos G; Manafi T; Logothetis J; Bostantzopoulou S
    Cephalalgia; 1985 May; 5 Suppl 2():135-40. PubMed ID: 3893733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
    Cerbo R; Casacchia M; Formisano R; Buzzi MG; Boni B; Feliciani M; Grillo G; Cusimano G; Agnoli A
    Riv Neurol; 1985; 55(2):139-46. PubMed ID: 4012191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of physical training and flunarizine on walking capacity in intermittent claudication.
    Lepäntalo M; Sundberg S; Gordin A
    Scand J Rehabil Med; 1984; 16(4):159-62. PubMed ID: 6397852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A preparation for the therapy of ischemic arterial diseases].
    Mueller-Duesberg P
    Med Klin; 1981 Mar; 76(7):197-9. PubMed ID: 7231334
    [No Abstract]   [Full Text] [Related]  

  • 18. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
    Verhaegen H; Reyntjens A; Horig C; Pötsch W
    Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
    [No Abstract]   [Full Text] [Related]  

  • 19. Flunarizine in the treatment of vertigo.
    Wouters L; Amery W; Towse G
    J Laryngol Otol; 1983 Aug; 97(8):697-704. PubMed ID: 6350513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of flunarizine on chronic cerebrovascular insufficiency: experience of a geriatric department].
    Ronchini P; D'Ambrosio E; Anesi E; Pellicioni P
    G Clin Med; 1982 Feb; 63(2):131-9. PubMed ID: 7106462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.